Pharmacogenetic studies in childhood acute lymphoblastic leukaemia with primary focus on methotrexate
Childhood acute lymphoblastic leukaemia is the most common type of cancer in children. Improvement in treatment has increased survival to approximately 85 per cent. Pharmacogenetics can influence the disposition of anticancer agents and can ideally be used as tool to further improve treatment based...
| Main Author: | |
|---|---|
| Format: | Doctoral Thesis |
| Language: | English |
| Published: |
Linköpings universitet, Klinisk farmakologi
2012
|
| Online Access: | http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-77625 http://nbn-resolving.de/urn:isbn:978-91-7519-929-0 |